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Sir,
Hepatocellular carcinoma (HCC) is the most com-
mon malignant disease and the number one cause
of death as a result of malignancy in Taiwan.
Surgical resection has been the standard local ther-
apy since William Keen reported using wedge re-
section for liver neoplasm in 1899. This practice
was not challenged until recently when less in-
vasive therapies emerged as alternatives, such as
percutaneous ethanol injection in the 1980s and
radiofrequency thermal ablation in the 1990s.
In the article “Is hepatectomy beneficial in the
treatment of multinodular hepatocellular carci-
noma?” by Wang et al in the August 2008 issue of
the journal,1 the overall 5-year survival of multi-
nodular HCC treated by hepatectomy was much
worse than that of single nodule HCC (29.9% vs.
58.4%). The recurrence of HCC after first resection
was extremely high at 88.8% (93/112). However,
both the treated and non-treated patients did not
add up to the number of recurrence of 93 as stated
in the article. The better choice of treatment for
recurrence is still controversial,2–5 even up to this
moment.
The data for nonsurgical treatment of the 874
patients selected as the concurrent control group
compared to the surgical treatment group were
not clearly stated in the article; therefore, it may
suffer from the issue of selection bias and a flaw in
data collection. Although the overall cumulative
survival was much better in the surgical group than
in the nonsurgical group up to 3 years (66.8% 
vs. 42.1%), it leveled off at 5 years (26.2% vs.
22.6%). Surgical resection is not any better than
nonsurgical treatment in the long term. Therefore,
ablation or surgery combined with ablation may
be an alternative option in treating multinodular
HCC.
It may require larger randomized controlled
trials to resolve this controversy despite the ex-
treme difficulty in conducting such a study in the
field of surgery.
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